发明名称 |
Use of a selective androgen receptor modulator compound for the preparation of a medicament for treating muscle wasting in a human subject with non-small cell lung cancer |
摘要 |
<p>This invention provides use of a SARM compound or a composition comprising the same in treating and preventing muscle wasting in patients with non-small cell lung cancer (NSCLC); treating pre-cachexia or early cachexia (preventing muscle wasting in a cancer patient); treating and preventing loss of physical function due to cancer or cancer therapy; increase of physical function; and increasing survival in a patient with NSCLC.</p> |
申请公布号 |
IL228766(D0) |
申请公布日期 |
2013.12.31 |
申请号 |
IL20130228766 |
申请日期 |
2013.10.07 |
申请人 |
UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION |
发明人 |
|
分类号 |
A61K |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|